Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Otsuka
Otsuka
Proteus, Otsuka take another run at FDA approval for Abilify-smart pill combo
Drug Delivery Business News
Wed, 05/24/17 - 10:50 am
Proteus
Otsuka
FDA
Abilify
smart pills
Otsuka acquires ADHD drug in $100M deal for Neurovance
BioPharma Dive
Mon, 03/6/17 - 11:48 am
Otsuka
ADHD
Neurovance
centanafadine
M&A
Lundbeck reads last rites on another failed PhIII Alzheimer’s program
Endpoints
Wed, 02/8/17 - 09:26 am
Lundbeck
Otsuka
Alzheimer's disease
idalopirdine
FDA Prevails in Otsuka Challenge to Scope of ABILIFY 3-Year Exclusivity, Leaving Intact ARISTADA 505(b)(2) NDA Approval
FDA Law Blog
Mon, 08/1/16 - 09:36 am
FDA
Otsuka
Abilify
exclusivity
Aristada
Alkermes
Commonly used drug can cause uncontrollable urge to gamble and have sex, FDA says
Stat
Tue, 05/3/16 - 09:53 pm
Abilify
antipsychotic
FDA
Otsuka
Bristol-Myers Squibb
FDA wants more from Proteus, Otsuka on ‘smart pill’
Mass Device
Wed, 04/27/16 - 10:04 pm
FDA
Proteus
Otsuka
Abilify
antidepressants
smart pills
Drug maker slammed for ‘ridiculously high’ price of TB drug
Stat
Thu, 02/25/16 - 03:13 pm
tuberculosis
drug pricing
delamanid
Otsuka
Sovaldi is expensive, but this drug cost N.C. Medicaid even more
Bizjournals.com
Wed, 12/16/15 - 10:55 am
Sovaldi
Gilead Sciences
drug pricing
North Carolina
Medicaid
Otsuka
Abilify
Massive gov't study promotes smaller drug doses, more talk therapy for schizophrenia
BioPharma Dive
Tue, 10/20/15 - 05:56 pm
schizophrenia
Otsuka
Abilify
Novartis
Clozaril
Are Researchers Giving This Illegal Drug the Green Light for Treating Chronic Pain?
Motley Fool
Sat, 10/17/15 - 03:23 pm
Medical Marijuana
GW Pharma
Otsuka
Otsuka wins early FDA approval for a colorectal cancer combo drug
Fierce Biotech
Tue, 09/22/15 - 01:55 pm
Otsuka
colorectal cancer
FDA
TAS-102
FDA to review Proteus ‘smart pill’ with Otsuka’s Abilify anti-depressant
Mass Device
Fri, 09/11/15 - 10:46 am
FDA
Proteus
Otsuka
Abilify
antidepressants
devices
smart pills
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
BioPharma Dive
Mon, 07/13/15 - 09:51 am
FDA
Otsuka
Lundbeck
schizophrenia
Rexulta
FDA approves Otsuka and Lundbeck's schizophrenia treatment
Yahoo/Reuters
Fri, 07/10/15 - 10:53 pm
FDA
Otsuka
Lundbeck
schizophrenia
Rexulti
antipsychotics
Bam! Bam! Two Plaintiffs Fall in Two District Court Decisions Concerning Orphan Drug Exclusivity Carve-Outs
FDA Law Blog
Fri, 05/29/15 - 10:23 am
Otsuka
Abilify
orphan drugs
exclusivity
Fusilev
Spectrum Pharmaceuticals
Otsuka loses lawsuit challenging FDA approval of generic Abilify
Yahoo/Reuters
Thu, 05/28/15 - 02:00 pm
Otsuka
FDA
Abilify
generics
Teva Pharmaceutical
It’s Been One of “Those Weeks” in Hatch-Waxman World: Another Two Lawsuits and Two Court Decisions
FDA Law Blog
Fri, 05/1/15 - 10:11 am
FDA
Hatch Waxman Act
Spectrum Pharmaceuticals
Boehringer Ingelheim
Otsuka
Otsuka pulling out all the stops to deter copycats of blockbuster Abilify
BioPharma Dive
Fri, 04/17/15 - 10:36 am
Otsuka
Abilify
Bristol-Myers Squibb
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
FDA is Sued by Otsuka for ‘Unlawfully’ Widening the Market for Abilify
WSJ Pharmalot
Thu, 03/26/15 - 09:30 pm
FDA
Otsuka
Abilify
antipsychotics
generics
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »